EP Patent

EP3877379A4 — CRYSTALLINE FORM OF NILOTINIB HYDROCHLORIDE, METHOD FOR PREPARING IT AND PHARMACEUTICAL COMPOSITION CONTAINING IT

Assigned to Laurus Labs Pvt Ltd · Expires 2022-08-31 · 4y expired

What this patent protects

Patent listed against nilotinib-hydrochloride.

Drugs covered by this patent

nilotinib-hydrochloride (Nilotinib Hydrochloride) · Jan Beumer

Patent Metadata

Patent number: EP3877379A4
Jurisdiction: EP
Classification: —
Expires: 2022-08-31
Drug substance claim: No
Drug product claim: No
Assignee: Laurus Labs Pvt Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.